Description of the blood test:

The Q-Fever antibody test is a specialized laboratory study used to detect an infection caused by the bacterium Coxiella burnetii. This pathogen is unique because it exists in two different antigenic forms, known as Phase I and Phase II. The immune system reacts differently to these phases depending on the duration of the infection. Testing for both phases is the gold standard for distinguishing between an acute (recent) infection and a chronic (long-term) infection, which can affect the heart or liver. This differentiation is critical for determining the appropriate duration and type of antibiotic therapy.

What does the analysis represent?

• Purpose: Quantitative determination of IgG and IgM antibodies to Coxiella burnetii Phase I and Phase II antigens.
• Primary application: Diagnosis of acute Q-fever, screening for chronic Q-fever (especially in patients with heart valve issues), and monitoring treatment effectiveness.
• Performance: High-precision Indirect Immunofluorescence Assay (IFA) or ELISA of a venous blood sample.

Recommendations for the test (General)

• Time: Blood collection is recommended during the morning hours.
• Fasting: It is necessary to observe a food intake pause of 4–8 hours before the procedure.
• Rest: Stay in a calm state for 15–30 minutes before the blood draw.
• Important: In acute cases, Phase II antibodies appear first. If Phase I antibodies are significantly higher, it often points toward a chronic or persistent infection.

What can affect the results?

• Timing: Testing too early (within the first week of symptoms) may yield a negative result; a second sample taken 2–3 weeks later is often required to see a rise in titers.
• Cross-reactivity: Occasionally, antibodies to other bacteria (like Legionella or Bartonella) can cause a weak positive result.

When to take the test?

• Recommendations: Prescribed for patients with prolonged high fever, severe headache, “atypical” pneumonia, or signs of liver inflammation (hepatitis), especially those who have had contact with farm animals.
• Preparation: Standard preparation for serological tests; exclude alcohol 24 hours prior.

How to interpret the results?

The interpretation of data is the exclusive responsibility of an infectious disease specialist or a pulmonologist. The ratio of Phase I to Phase II antibodies is a complex clinical marker and not a final diagnosis. The physician analyzes the results to determine the stage of the disease: typically, a high Phase II titer suggests an acute process, while a high Phase I titer requires investigation for chronic complications. Only an expert can use these titers to decide on the necessity of long-term specialized treatment.

Possible further investigations

• Echocardiogram (Echo): To rule out heart valve involvement (endocarditis) in cases of suspected chronic Q-fever.
• Liver Function Tests (ALT, AST): To assess if the infection is affecting the liver.
• Chest X-ray: To evaluate for signs of pneumonia.
• Consultation with a Pulmonologist: For specialized management of respiratory symptoms associated with the infection.

When does the next step make sense?

A positive result requires professional medical management, as Q-fever can sometimes lead to persistent health issues if not treated correctly. The next step is a consultation to confirm the stage of the infection and to ensure that the heart and lungs are protected through a targeted clinical plan.

👉 If necessary, you can discuss the test results with our specialized — pulmonologist (Doctors – TAMC).